Tag - avigan

 
 

AVIGAN

Japan Times
JAPAN
Mar 11, 2022
Fujifilm to halt enrollment in Avigan trial for COVID-19
The emergence of the omicron variant, which usually causes milder infections, made it tough to determine the drug's effectiveness in preventing severe symptoms, the company said.
Japan Times
JAPAN
Mar 9, 2021
Drugmakers in Japan struggle to keep pace in COVID-19 medicine race
No applications for drugs specifically tailored to COVID-19 have been filed yet, as domestic pharmaceutical companies have not invested heavily enough in biomedicine.
Japan Times
JAPAN / Science & Health
Feb 21, 2021
Fujifilm to restart trial of Avigan to treat COVID-19, report says
Domestic approval of the drug was delayed after a health ministry panel said in December that trial data was inconclusive.
Japan Times
BUSINESS / Companies
Oct 22, 2020
Fujifilm works with Shanghai firm to get Avigan approved in China
Fujifilm Holdings Corp. said on Thursday it has partnered with Shanghai-based Carelink Pharmaceutical Co. to seek approval in China for Avigan to treat COVID-19 and influenza.
Japan Times
BUSINESS / Companies
Oct 16, 2020
Fujifilm seeks approval for Avigan as COVID-19 treatment in Japan
The move comes after a late-stage study showed reduced recovery times for patients with nonsevere symptoms.
Japan Times
JAPAN / Science & Health
Jul 10, 2020
Avigan's effectiveness inconclusive in Japan COVID-19 trial
Promoted heavily by Prime Minister Shinzo Abe, the flu drug did not yield any statistically significant results after administered to 89 patients across Japan.
Japan Times
JAPAN / Science & Health
Jun 24, 2020
Wanted: More COVID-19 patients in Japan ... for clinical trials
Japan has become a victim of its own success as slowing new infections have led to a shortage of patients to enroll in trials for treatments and vaccines.
Japan Times
WORLD / Science & Health
Jun 1, 2020
After fast-tracking Japanese COVID-19 drug, Russia to roll out 'game changer' next week
Russia will start administering its first approved antiviral drug to treat coronavirus patients next week, its state financial backer told Reuters, a move it described as "a game changer" that should speed a return to normal economic life.
Japan Times
BUSINESS
May 21, 2020
No pause in coronavirus trial for Avigan, Japan's lead researcher says
The lead researcher in the coronavirus trial for flu drug Avigan says it’s too early to make a call on whether it works and shrugged off negative reports about the interim results, saying patients are still being enrolled.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?